Easterly Investment Partners LLC Invests $986,000 in Avanos Medical, Inc. (NYSE:AVNS)

Easterly Investment Partners LLC bought a new position in shares of Avanos Medical, Inc. (NYSE:AVNS) in the first quarter, HoldingsChannel reports. The fund bought 68,833 shares of the company’s stock, valued at approximately $986,000.

Other large investors also recently bought and sold shares of the company. Comerica Bank increased its holdings in Avanos Medical by 3.4% in the fourth quarter. Comerica Bank now owns 22,903 shares of the company’s stock valued at $365,000 after buying an additional 755 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Avanos Medical by 3.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company’s stock worth $411,000 after acquiring an additional 901 shares in the last quarter. EP Wealth Advisors LLC boosted its holdings in shares of Avanos Medical by 14.6% in the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company’s stock valued at $161,000 after buying an additional 1,289 shares during the period. Azzad Asset Management Inc. ADV boosted its stake in Avanos Medical by 3.5% during the 1st quarter. Azzad Asset Management Inc. ADV now owns 41,039 shares of the company’s stock valued at $588,000 after purchasing an additional 1,404 shares during the period. Finally, Gotham Asset Management LLC lifted its stake in shares of Avanos Medical by 5.3% in the 4th quarter. Gotham Asset Management LLC now owns 28,234 shares of the company’s stock worth $449,000 after acquiring an additional 1,425 shares during the period. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Stock Up 1.7%

Avanos Medical stock opened at $11.65 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.56 and a current ratio of 2.57. Avanos Medical, Inc. has a twelve month low of $11.21 and a twelve month high of $25.36. The firm’s 50 day moving average price is $12.35 and its two-hundred day moving average price is $13.90. The firm has a market cap of $538.83 million, a PE ratio of -1.39 and a beta of 1.12.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07. Avanos Medical had a negative net margin of 55.80% and a positive return on equity of 6.26%. The business had revenue of $167.50 million for the quarter, compared to analyst estimates of $161.75 million. During the same quarter last year, the firm earned $0.22 EPS. Avanos Medical’s quarterly revenue was up .8% compared to the same quarter last year. On average, research analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.